Host: Demondes Haynes, MD

Guest: Njira Lugogo, MD

Guest: Neil Skolnik, MD

According to data from the CDC, over half of patients in the United States are not considered well controlled, and there hasn’t been much improvement in exacerbations as measured by ER visits or by deaths per year in the last 30 years or so. But fortunately, the use of single maintenance and reliever therapy (SMART) has been shown to help address inflammation and decrease exacerbations. Drs. Demondes Haynes, Njira Lugogo, and Neil Skolnik discuss this approach and other combination treatment for asthma.

This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.